- Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2
Yue Zhang et al, 2022, Bioengineered CrossRef - 20(S)- Protopanaxadiol suppresses hepatic stellate cell activation via WIF1 demethylation-mediated inactivation of the Wnt/β-catenin pathway
Chunxue Li et al, 2023, Journal of Ginseng Research CrossRef - SFRP4+IGFBP5hi NKT cells induced neural-like cell differentiation to contribute to adenomyosis pain
Yichen Chen et al, 2022, Frontiers in Immunology CrossRef - Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh et al, 2021, Journal of Hepatocellular Carcinoma CrossRef - miR-148b-3p, as a tumor suppressor, targets son of sevenless homolog 1 to regulate the malignant progression in human osteosarcoma
Guodong Liu et al, 2022, Bioengineered CrossRef - SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway
Ruihong Lan et al, 2024, Molecular Medicine Reports CrossRef - New treatment strategies for uterine sarcoma using secreted frizzled‑related proteins
Tomohiro Kagawa et al, 2024, Experimental and Therapeutic Medicine CrossRef - SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer
Pengcheng Yu et al, 2022, Journal of Oncology CrossRef - Secreted frizzled-related proteins: A promising therapeutic target for cancer therapy through Wnt signaling inhibition
Wenqiang Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef